IQVIA Holdings Inc. – NYSE:IQV

IQVIA Holdings stock price today

$191.44
-7.94
-3.99%
Financial Health
0
1
2
3
4
5
6
7
8
9

IQVIA Holdings stock price monthly change

-11.05%
month

IQVIA Holdings stock price quarterly change

-11.05%
quarter

IQVIA Holdings stock price yearly change

-14.03%
year

IQVIA Holdings key metrics

Market Cap
35.86B
Enterprise value
48.87B
P/E
35.16
EV/Sales
3.39
EV/EBITDA
9.88
Price/Sales
2.57
Price/Book
6.43
PEG ratio
2.30
EPS
7.43
Revenue
15.11B
EBITDA
3.34B
Income
1.35B
Revenue Q/Q
2.40%
Revenue Y/Y
4.27%
Profit margin
7.57%
Oper. margin
12.48%
Gross margin
34.89%
EBIT margin
12.48%
EBITDA margin
22.12%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

IQVIA Holdings stock price history

IQVIA Holdings stock forecast

IQVIA Holdings financial statements

Average Price Target
Last Year

$249.63

Potential upside: 30.39%

Based on estimate of 7 analysts
  • Analysts Price target

  • Financials & Ratios estimates

IQVIA Holdings Inc. (NYSE:IQV): Profit margin
Jun 2023 3.72B 297M 7.97%
Sep 2023 3.73B 303M 8.11%
Dec 2023 3.90B 469M 12%
Mar 2024 3.74B 288M 7.7%
IQVIA Holdings Inc. (NYSE:IQV): Debt to assets
Jun 2023 26036000000 20.28B 77.92%
Sep 2023 25977000000 20.17B 77.65%
Dec 2023 26681000000 20.56B 77.09%
Mar 2024 26574000000 20.23B 76.13%
IQVIA Holdings Inc. (NYSE:IQV): Cash Flow
Jun 2023 402M -596M 95M
Sep 2023 583M -573M -144M
Dec 2023 747M -212M -420M
Mar 2024 522M -314M -106M

IQVIA Holdings alternative data

IQVIA

IQVIA Holdings Inc. (NYSE:IQV): Google Trends - IQVIA
19 Feb 2023 58
26 Feb 2023 53
5 Mar 2023 55
12 Mar 2023 65
19 Mar 2023 66
26 Mar 2023 61
2 Apr 2023 66
9 Apr 2023 66
16 Apr 2023 58
23 Apr 2023 63
30 Apr 2023 60
7 May 2023 64
14 May 2023 55
21 May 2023 52
28 May 2023 56
4 Jun 2023 58
11 Jun 2023 56
18 Jun 2023 61
25 Jun 2023 60
2 Jul 2023 58

Numbers represent search interest relative to the highest point on the chart for the given region and time.

A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.

IQVIA Holdings Inc. (NYSE:IQV): Job openings
Aug 2023 3,953
Sep 2023 3,517
Oct 2023 3,421
Nov 2023 3,274
Dec 2023 3,231
Jan 2024 2,357
Feb 2024 3,246
Apr 2024 2,384
May 2024 2,984
Jun 2024 2,142
Jul 2024 2,042
Dec 2024 2,479
IQVIA Holdings Inc. (NYSE:IQV): Employee count
Aug 2023 87,000
Sep 2023 87,000
Oct 2023 87,000
Nov 2023 87,000
Dec 2023 87,000
Jan 2024 87,000
Feb 2024 87,000
Mar 2024 87,000
Apr 2024 87,000
May 2024 87,000
Jun 2024 87,000
Jul 2024 87,000

IQVIA Holdings other data

83.35% -1.67%
of IQV is owned by hedge funds
162.52M -3.50M
shares is hold by hedge funds

IQVIA Holdings Inc. (NYSE:IQV): Insider trades (number of shares)
Period Buy Sel
May 2023 0 1
Jun 2023 0 5820
Sep 2023 0 27317
Dec 2023 0 13117
Feb 2024 0 37175
Mar 2024 0 31678
Transaction Date Insider Security Shares Price per share Total value Source
Option
BOUSBIB ARI director, officer.. Common Stock 42,847 $65.16 $2,791,911
Option
BOUSBIB ARI director, officer.. Common Stock 42,847 $65.16 $2,791,911
Sale
BOUSBIB ARI director, officer.. Common Stock 16,261 $250.05 $4,066,063
Sale
BOUSBIB ARI director, officer.. Common Stock 16,261 $250.05 $4,066,063
Sale
BOUSBIB ARI director, officer.. Common Stock 15,417 $251.03 $3,870,130
Sale
BOUSBIB ARI director, officer.. Common Stock 15,417 $251.03 $3,870,130
Option
BOUSBIB ARI director, officer.. Stock Appreciation Right 42,847 $65.16 $2,791,911
Option
BOUSBIB ARI director, officer.. Stock Appreciation Right 42,847 $65.16 $2,791,911
Sale
STAUB W RICHARD officer: See Rema.. Common Stock 8,970 $247.33 $2,218,550
Sale
STAUB W RICHARD officer: See Rema.. Common Stock 8,970 $247.33 $2,218,550
Monday, 23 December 2024
zacks.com
businesswire.com
Thursday, 19 December 2024
https://thefly.com
Thursday, 12 December 2024
seekingalpha.com
Thursday, 28 November 2024
zacks.com
Monday, 4 November 2024
zacks.com
Thursday, 31 October 2024
zacks.com
seekingalpha.com
zacks.com
reuters.com
zacks.com
businesswire.com
Monday, 28 October 2024
zacks.com
zacks.com
Thursday, 24 October 2024
zacks.com
Tuesday, 15 October 2024
businesswire.com
Friday, 4 October 2024
zacks.com
zacks.com
Thursday, 19 September 2024
businesswire.com
Tuesday, 17 September 2024
zacks.com
zacks.com
Thursday, 12 September 2024
zacks.com
Wednesday, 4 September 2024
benzinga.com
prnewswire.com
Wednesday, 21 August 2024
zacks.com
Tuesday, 20 August 2024
seekingalpha.com
Friday, 16 August 2024
zacks.com
Monday, 1 July 2024
zacks.com
Tuesday, 25 June 2024
businesswire.com
Thursday, 13 June 2024
zacks.com
  • What's the price of IQVIA Holdings stock today?

    One share of IQVIA Holdings stock can currently be purchased for approximately $191.44.

  • When is IQVIA Holdings's next earnings date?

    Unfortunately, IQVIA Holdings's (IQV) next earnings date is currently unknown.

  • Does IQVIA Holdings pay dividends?

    No, IQVIA Holdings does not pay dividends.

  • How much money does IQVIA Holdings make?

    IQVIA Holdings has a market capitalization of 35.86B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3.98% to 14.98B US dollars.

  • What is IQVIA Holdings's stock symbol?

    IQVIA Holdings Inc. is traded on the NYSE under the ticker symbol "IQV".

  • What is IQVIA Holdings's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of IQVIA Holdings?

    Shares of IQVIA Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are IQVIA Holdings's key executives?

    IQVIA Holdings's management team includes the following people:

    • Mr. Ari Bousbib Chairman, Pres & Chief Executive Officer(age: 64, pay: $8,760,000)
    • Mr. Ronald E. Bruehlman Executive Vice President & Chief Financial Officer(age: 64, pay: $1,670,000)
    • Mr. W. Richard Staub III Pres of R&D Solutions(age: 62, pay: $1,450,000)
    • Mr. Eric M. Sherbet Executive Vice President, Gen. Counsel & Sec.(age: 61, pay: $1,240,000)
    • Mr. Kevin C. Knightly Pres of Technology & Commercial Solutions(age: 64, pay: $1,230,000)
  • How many employees does IQVIA Holdings have?

    As Jul 2024, IQVIA Holdings employs 87,000 workers.

  • When IQVIA Holdings went public?

    IQVIA Holdings Inc. is publicly traded company for more then 12 years since IPO on 9 May 2013.

  • What is IQVIA Holdings's official website?

    The official website for IQVIA Holdings is iqvia.com.

  • Where are IQVIA Holdings's headquarters?

    IQVIA Holdings is headquartered at 4820 Emperor boulevard, Durham, NC.

  • How can i contact IQVIA Holdings?

    IQVIA Holdings's mailing address is 4820 Emperor boulevard, Durham, NC and company can be reached via phone at +91 99982000.

  • What is IQVIA Holdings stock forecast & price target?

    Based on 7 Wall Street analysts` predicted price targets for IQVIA Holdings in the last 12 months, the avarage price target is $249.63. The average price target represents a 30.39% change from the last price of $191.44.

IQVIA Holdings company profile:

IQVIA Holdings Inc.

iqvia.com
Exchange:

NYSE

Full time employees:

88,000

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

4820 Emperor boulevard
Durham, NC 27703

CIK: 0001478242
ISIN: US46266C1053
CUSIP: 46266C105